Vicarious Surgical (NYSE:RBOT) Trading 1% Higher

Vicarious Surgical Inc (NYSE:RBOTGet Free Report)’s share price traded up 1% during trading on Thursday . The stock traded as high as $6.10 and last traded at $5.86. 7,904 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 26,929 shares. The stock had previously closed at $5.80.

Analyst Upgrades and Downgrades

RBOT has been the subject of several research analyst reports. Piper Sandler cut their target price on Vicarious Surgical from $30.00 to $12.00 and set a “neutral” rating for the company in a research report on Tuesday, August 13th. Morgan Stanley dropped their price target on Vicarious Surgical from $18.00 to $10.00 and set an “equal weight” rating for the company in a research note on Monday, July 15th.

Read Our Latest Research Report on Vicarious Surgical

Vicarious Surgical Stock Performance

The company has a market cap of $34.42 million, a PE ratio of -0.51 and a beta of 1.12. The company has a fifty day moving average of $6.58 and a two-hundred day moving average of $8.24.

Vicarious Surgical (NYSE:RBOTGet Free Report) last announced its earnings results on Monday, August 12th. The company reported ($2.86) earnings per share for the quarter, beating the consensus estimate of ($2.98) by $0.12. On average, equities analysts forecast that Vicarious Surgical Inc will post -10.07 EPS for the current year.

About Vicarious Surgical

(Get Free Report)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Read More

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.